ImVisioN Therapeutics
Latest round
- Series A
Last raised
- Sep 2008
Total raised
- $4.5M
Investors
- 2
About ImVisioN Therapeutics
mVisioN Therapeutics is a biotechnology company that is pioneering the use of intralymphatic immunotherapy to develop safe, effective and convenient treatments for major allergies.
Who invested in ImVisioN Therapeutics
2 investors across 1 round
See all investors in ImVisioN Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 10, 2008
Amount
$4.5M
Investors
Questions about ImVisioN Therapeutics
Who invested in ImVisioN Therapeutics?
ImVisioN Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImVisioN Therapeutics raised?
ImVisioN Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImVisioN Therapeutics last raise money?
ImVisioN Therapeutics's most recent round on record is a Series A, in Sep 2008.
What does ImVisioN Therapeutics do?
mVisioN Therapeutics is a biotechnology company that is pioneering the use of intralymphatic immunotherapy to develop safe, effective and convenient treatments for major allergies.
Where is ImVisioN Therapeutics headquartered?
ImVisioN Therapeutics is headquartered in Muttenz, Switzerland.
Which VCs invest in companies like ImVisioN Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at ImVisioN Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ImVisioN Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.